IVF Reads / Infections That Harm Sperm: Which Ones Actually Matter
Infections That Harm Sperm: Which Ones Actually Matter

The infections that measurably damage male fertility are mumps orchitis after puberty, chlamydia and gonorrhoea reaching the epididymis, and genital tuberculosis. The reported prevalence of orchitis among young adult men with mumps is as high as 40%, it is bilateral in 10% to 30% of those cases, and the reported prevalence of subfertility or infertility among post-pubertal men with mumps orchitis is around 30% (Wu H et al, Frontiers in Immunology 2021;12:582946). Reported prevalence of tuberculosis as the cause among infertile men with obstructive azoospermia is 4% to 9.1%, and genital involvement may be commoner in India than elsewhere (Yadav S et al, Translational Andrology and Urology 2017;6(2):222-233). White blood cells on a semen report are a separate matter: the EAU 2025 guideline states that leucocytospermia "is not necessarily associated with bacterial or viral infections and therefore cannot be considered a reliable indicator", and that there is no evidence that treating it without evidence of an infective organism improves conception rates. Routine empiric antibiotics for asymptomatic leucocytospermia are not recommended.
- Minhas S, Boeri L, Capogrosso P, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility. European Urology 2025;87(5):601-616, PMID 40118737. On leucocytospermia: "Although leukocytospermia is a sign of inflammation, it is not necessarily associated with bacterial or viral infections and therefore cannot be considered a reliable indicator"; "There is currently no evidence that treatment of leukocytospermia alone without evidence of infective organisms improves conception rates." Summary of evidence, Level 2a: "Although antibiotic treatment for male accessory gland infections may result in improvement in sperm quality, it does not enhance the probability of conception"; and antibiotic treatment "cannot reverse functional deficits and anatomical abnormalities". Recommendation at Strong strength: refer sexual partners of patients with accessory gland infections known or suspected to be sexually transmitted for evaluation and treatment.
- Yadav S, Singh P, Hemal A, Kumar R. Genital tuberculosis: current status of diagnosis and management. Translational Andrology and Urology 2017;6(2):222-233, PMID 28540230. Genitourinary tuberculosis is the second most common extrapulmonary manifestation of tuberculosis; isolated genital involvement occurs in about 5% to 30% of genitourinary cases and may be commoner in India than in other countries. About 10% of men with genital tuberculosis present with infertility, and around 4% to 9.1% of infertile men with a clinical diagnosis of obstructive azoospermia have tuberculosis as the cause. Infertility from genital tuberculosis "may persist even after successful chemotherapy", multi-site obstruction is characteristic, and most cases are not amenable to surgical reconstruction so assisted reproduction is usually required.
- Wu H, Wang F, Tang D, Han D. Mumps orchitis: clinical aspects and mechanisms. Frontiers in Immunology 2021;12:582946, PMID 33815357. Orchitis is the most common extra-salivary complication of mumps and "occurs in as high as 40% of all mumps cases in young adult men"; it is "mostly unilateral, but can occur bilaterally in 10-30% of cases"; "Approximately 30% of mumps orchitis in post pubertal males suffer from infertility or subfertility". It generally appears about a week after the onset of parotitis. These figures are the review's own citations of primary reports.
- Campbell KJ, Venkatesh A, Golan R, et al. Impact of male genital tract infections on semen quality: a systematic review and meta-analysis. Fertility and Sterility 2026;125(5):770-783, PMID 41825760. 51 studies qualitatively, 35 in meta-analysis, all comparing men with documented genitourinary infection against non-infected controls. Mean differences: semen volume -0.37 mL (95% CI -0.64 to -0.09), sperm concentration -6.65 million/mL (-11.17 to -2.14), progressive motility -5.93 percentage points (-9.07 to -2.78), total sperm count -47.15 million (-91.42 to -2.88), morphology -0.76 percentage points (-1.19 to -0.33). Total motility, vitality and DNA fragmentation index were NOT significantly different between groups, and most pregnancy and live birth outcomes did not significantly differ between infected and control groups. Hepatitis B was associated with increased miscarriage risk (odds ratio 1.43, 95% CI 1.05 to 1.93). Heterogeneity was substantial across outcomes (I2 66% to 95%).
- Gupta R, Singh P, Kumar R. Should men with idiopathic obstructive azoospermia be screened for genitourinary tuberculosis? Journal of Human Reproductive Sciences 2015;8(1):43-7, PMID 25838748. 100 infertile Indian men with idiopathic obstructive azoospermia were screened with semen tuberculosis PCR. Seven were positive; four of those had other clinical evidence of tuberculosis and received six months of anti-tubercular therapy; none had any improvement in semen parameters. Authors' conclusion: screening by semen PCR "did not identify any men who would have been missed on clinical evaluation and is thus not indicated in men with idiopathic obstructive azoospermia".
- Reich MC, Heide N, Humaidan P, Esteves SC. Asymptomatic leukocytospermia and assisted reproductive technology outcomes: reason for concern? International Brazilian Journal of Urology 2025;51(5), PMID 40209117. Narrative review synthesising meta-analyses and large retrospective studies: asymptomatic leucocytospermia does not negatively affect fertilisation, embryo development, clinical pregnancy or live birth, and standard sperm preparation with ICSI appears to neutralise any potential effect. "Given the absence of compelling evidence supporting its harmful impact on ART success, routine treatment of asymptomatic leukocytospermia — particularly with empiric antibiotics — is not recommended. Such interventions may disturb the natural immune balance, promote antibiotic resistance, and increase healthcare burdens without demonstrable benefit."
Which infections actually damage male fertility?
Three matter most: mumps affecting the testicles after puberty, chlamydia or gonorrhoea that has reached the epididymis, and genital tuberculosis, which is under-discussed and may be commoner in India than elsewhere. All three can leave permanent damage. Most of the other infections named on fertility pages either do less than is claimed or have not been shown to do anything measurable.
The honest framing from the guidelines is more cautious than most of what is written about this. The EAU 2025 guideline lists male accessory gland infections — urethritis, prostatitis, orchitis, epididymitis — and records in its own summary of evidence that they are "not clearly associated with impaired natural conception". A systematic review it cites was "unable to draw a strong association between STIs and male infertility due to the limited quality of reported data".
The two things that separate a scare from real harm are whether the infection reached the testis or the ducts, and whether scarring followed. That is what the rest of this page is about.
My semen report says leucocytospermia. Do I need antibiotics?
Almost certainly not on that finding alone. White blood cells in semen mean inflammation, which is not the same thing as infection. The EAU guideline states that leucocytospermia "is not necessarily associated with bacterial or viral infections and therefore cannot be considered a reliable indicator".
It is also a lower bar than it sounds. The threshold is one million white cells per millilitre of semen, and it should be confirmed with a peroxidase stain rather than accepted from a routine count. Bacteria are a separate test: significant bacteriospermia needs more than a thousand colony-forming units per millilitre of a urinary tract pathogen grown from the ejaculate.
On treatment, the guideline is explicit: there is currently no evidence that treating leucocytospermia alone, without evidence of an infective organism, improves conception rates. A 2025 review of asymptomatic leucocytospermia goes further — routine treatment, and particularly empiric antibiotics, is not recommended, because it may disturb the immune balance, promote antibiotic resistance and add cost without demonstrable benefit.
What is worth doing is asking two questions: do I have any symptoms, and has a culture or PCR actually been done. If the answer to both is no, an antibiotic is being given to a number on a page rather than to an infection.
Mumps after puberty: how much damage, and why this matters in India
Mumps in a grown man is not the same illness as mumps in a child. Orchitis — inflammation of one or both testicles — is the commonest complication outside the salivary glands, and in young adult men it has been reported in as many as 40 of every 100 mumps cases. It usually appears about a week after the parotid swelling.
Most cases involve one testicle. Both are affected in 10 to 30 of every 100 men with mumps orchitis, and roughly 30 of every 100 post-pubertal men who get mumps orchitis are left subfertile or infertile. Those are the figures a review of the condition draws from the primary reports.
The Indian part of this is specific and checkable: the mumps vaccine is not in India's national immunisation programme, which covers measles and rubella. In a 2023-24 outbreak in Shivamogga, Karnataka, every laboratory-confirmed case among 318 children was unvaccinated for mumps, and the complication rate climbed with age — none of those under five years, 1.9% at five to nine years, and 19.2% at ten years and above (risk ratio 10.1, 95% CI 3.0 to 34.3). Of 508 children tested in Kerala, 78.5% carried mumps antibody against 99.4% for rubella.
What follows for an adult man is limited but real. If you had mumps with testicular pain and swelling after puberty, that belongs in your history, and a semen analysis is a reasonable thing to ask for rather than something to wait for. If you have never had mumps and are not immune, MMR vaccination is a conversation to have with a doctor before conception, not during a pregnancy.
Want your own results explained?
IVY can read your reports alongside your history and set out what the evidence supports for your situation — and what it does not.
Genital tuberculosis: the cause most often missed in India
Genitourinary tuberculosis is the second most common form of tuberculosis outside the lungs, and in 5 to 30 of every 100 such cases only the genital organs are involved. There is evidence that genital involvement is commoner in India than in other countries. The epididymis is the organ most often affected.
It is easy to miss because of how it presents. The commonest sign is a painless lump in the scrotum. It typically reactivates decades after the original lung infection — about 30 years on average, with a reported range of 1 to 46 — so there may be no history of tuberculosis to give, and infertility can be the first thing anyone notices. About 10 in every 100 men with genital tuberculosis present with infertility, and tuberculosis is the cause in 4 to 9 of every 100 infertile men diagnosed with obstructive azoospermia.
Treatment is standard anti-tubercular therapy — two months of four drugs, then four months of two. What matters for fertility is that curing the infection does not undo the scarring. Infertility from genital tuberculosis is described as multifactorial and may persist even after successful chemotherapy, obstruction at several points at once is characteristic, and most such cases cannot be reconstructed surgically, so assisted reproduction using surgically retrieved sperm is usually what is left.
One thing to be careful about, because it is widely sold in India. A study of 100 infertile men with unexplained obstructive azoospermia screened them all with a semen tuberculosis PCR. Seven tested positive; four had other clinical evidence of tuberculosis and were treated for six months; none of the four had any improvement in semen parameters. The authors concluded the test found nobody who would have been missed by examination and history, and is not indicated in that situation. Examination first, not the PCR.
Treatable infection or permanent blockage — how is that told apart?
This is the distinction that decides everything that follows, and it is not made by a semen culture. An active infection can be treated. Scarring that has already closed the epididymis or the vas cannot be treated with drugs at all.
The things that separate the two are ordinary: an examination of the scrotum for nodules or a thickened vas, testicular volume, FSH, and whether there is any sperm at all in the ejaculate. Azoospermia with normal testicular volume and normal FSH points towards a blockage; azoospermia with small testes and a high FSH points towards a production problem. Those two are managed completely differently.
This is also why the guideline language about antibiotics is worded the way it is. Antibiotics eradicate organisms. They have no effect on inflammatory changes that have already happened and cannot reverse anatomical damage. Clearing an infection is worth doing on its own terms; it is not a fertility treatment.
When does this need to be seen quickly?
Pain and swelling in a testicle is the one that should not wait. Sudden severe testicular pain needs same-day assessment, because testicular torsion looks similar and is time-critical. Pain with fever, or pain with discharge or burning on passing urine, needs seeing promptly too.
Acute epididymitis in sexually active men is most often caused by Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma genitalium, and the accompanying urethritis is frequently asymptomatic — which is exactly how these infections reach the epididymis unnoticed. The CDC lists infertility and chronic pain among the complications that treatment aims to avoid, without giving a rate for either.
If a sexually transmitted infection is diagnosed or suspected, the EAU guideline's one Strong recommendation in this area is about your partner, not about you: sexual partners should be referred for evaluation and treatment. Untreated reinfection is how a single episode becomes repeated episodes.
What the evidence does not establish
Most of what gets written about infections and sperm sits in this section, including much of what this page used to say.
- It does not establish that infections substantially reduce the chance of a pregnancy. Pooling 35 control-comparator studies, most pregnancy and live birth outcomes did not differ significantly between infected men and non-infected controls.
- It does not establish that infection raises sperm DNA fragmentation. In that same pooled analysis, total motility, vitality and DNA fragmentation index were not significantly different between groups.
- It does not establish that treating leucocytospermia helps. The EAU states there is no evidence that treating it without evidence of an infective organism improves conception rates, and grades the data on antibiotics plus antioxidants for it as insufficient.
- It does not establish a strong link between sexually transmitted infections generally and male infertility. The systematic review the EAU cites was unable to draw one, because of the quality of the available data.
- It does not establish what antiviral or antiretroviral treatment does to sperm. The live version of this page claimed effects for HIV therapy, hepatitis B and Zika that no source retrieved here supports; they have been removed rather than left standing.
- It does not establish that hygiene, diet or sleep protect fertility from infection. Those claims were on this page and are gone.
There is one thing worth saying plainly to anyone reading this after an episode of testicular pain years ago. Whether damage was done is a question a semen analysis and an examination can answer in a fortnight, and not knowing is usually harder than knowing. Sometimes the answer turns out to be testing, timing or a simpler treatment rather than IVF.
Related reading
Not sure what your results mean?
Upload your test results and IVY will explain what has been checked, what it shows, and what usually comes next.
Keep reading
10 Sources
- Minhas S, Boeri L, Capogrosso P, Cocci A, Corona G, Dinkelman-Smit M, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Infertility. European Urology. 2025;87(5):601-616. PMID 40118737. Practice guideline; chapter text retrieved from uroweb.org on 28 September 2026. On white cells: "Although leukocytospermia is a sign of inflammation, it is not necessarily associated with bacterial or viral infections and therefore cannot be considered a reliable indicator"; leucocytospermia is defined as more than one million white blood cells per millilitre and should be confirmed by peroxidase test; more than a thousand colony-forming units per millilitre of urinary tract pathogens in the ejaculate indicates significant bacteriospermia; "A meta-analysis of case-control studies showed that leukocytospermia in males seeking consultation for couple subfertility was not associated with reduced fertility after ART and altered semen quality in males without symptoms of genital tract infections"; "There is currently no evidence that treatment of leukocytospermia alone without evidence of infective organisms improves conception rates." Summary of evidence: male accessory gland infections are not clearly associated with impaired natural conception (Level 3); antibiotic treatment often only eradicates micro-organisms, has no positive effect on inflammatory alterations and cannot reverse functional deficits and anatomical abnormalities (Level 2a); antibiotic treatment may improve sperm quality but does not enhance the probability of conception (Level 2a); data are insufficient on antibiotics and antioxidants for leucocytospermia (Level 3). Recommendations: treat male accessory gland infections (Weak); refer sexual partners where a sexually transmitted cause is known or suspected (Strong). Also records a systematic review that "was unable to draw a strong association between STIs and male infertility due to the limited quality of reported data". Integrity check 28 September 2026: no retraction, expression of concern or erratum. Supports the leucocytospermia section, the antibiotic corrections and the partner recommendation. European Association of Urology
- Yadav S, Singh P, Hemal A, Kumar R. Genital tuberculosis: current status of diagnosis and management. Translational Andrology and Urology. 2017;6(2):222-233. PMID 28540230. PMC full text retrieved and read 28 September 2026. Genitourinary tuberculosis is the second most common extrapulmonary manifestation of tuberculosis; isolated genital involvement is reported in about 5-30% of genitourinary cases; "there is some evidence that genital involvement from Tb might be commoner in India as compared to other countries"; the epididymis is the commonest organ involved, by haematogenous spread; commonly affects men aged 30-50; reactivation follows a latent period of about 30 years, range 1-46; commonest presentation is a painless scrotal mass; "About 10% of the patients with genital Tb may present with infertility and around 4% to 9.1% of men with infertility with a clinical diagnosis of obstructive azoospermia have Tb as the cause"; standard treatment is 2 months HRZE then 4 months HR; "Infertility resulting from tubercular affliction of genitalia is multifactorial in origin and may persist even after successful chemotherapy"; multiple-site obstruction is characteristic and most cases are not amenable to surgical reconstruction, so assisted reproduction is usually required. No retraction, expression of concern or erratum. Supports the whole genital tuberculosis section. Translational Andrology and Urology
- Gupta R, Singh P, Kumar R. Should men with idiopathic obstructive azoospermia be screened for genitourinary tuberculosis? Journal of Human Reproductive Sciences. 2015;8(1):43-7. PMID 25838748. 100 infertile men with idiopathic obstructive azoospermia screened with a kit-based semen tuberculosis PCR. Seven (7%) were positive. Four of the seven had other clinical evidence of tuberculosis on history and physical signs and were given six months of anti-tubercular therapy; none had any improvement in semen parameters. No subject had any other laboratory evidence of tuberculosis. Authors' conclusion: "Screening for TB using semen PCR did not identify any men who would have been missed on clinical evaluation and is thus not indicated in men with idiopathic obstructive azoospermia." No retraction, expression of concern or erratum. Supports the warning against routine semen tuberculosis PCR. Journal of Human Reproductive Sciences
- Wu H, Wang F, Tang D, Han D. Mumps orchitis: clinical aspects and mechanisms. Frontiers in Immunology. 2021;12:582946. PMID 33815357. PMC full text retrieved and read 28 September 2026. Orchitis is the most common extra-salivary gland inflammation in mumps and "occurs in as high as 40% of all mumps cases in young adult men"; "Mumps orchitis is mostly unilateral, but can occur bilaterally in 10-30% of cases"; "Approximately 30% of mumps orchitis in post pubertal males suffer from infertility or subfertility"; orchitis generally manifests around a week after the onset of parotitis; it may lead to atrophy of the germinal epithelium with arrest of spermatogenesis. NOTE: these percentages are the review's citations of primary reports, and the primary reports were not individually retrieved for this page. No retraction, expression of concern or erratum on the review. Supports the mumps figures. Frontiers in Immunology
- Gireesh S, Sakaleshpur Kumar V, S R R. Mumps outbreak in Shivamogga, India (2023-2024): age-specific attack rates, complications, and an economic case for measles-mumps-rubella vaccine inclusion in the Universal Immunization Programme. Cureus. 2026;18(1):e101201. PMID 41669588. Retrospective outbreak investigation, epidemiologic weeks 49-2023 to 8-2024, Shivamogga, Karnataka. Opening statement: "Recurrent mumps outbreaks continue to be reported in India, where the vaccine is not part of the national immunization schedule." Of approximately 2,500 clinically suspected cases, 318 children were IgM-confirmed (median age 6.5 years). Complications in nine children (2.8%, 95% CI 1.3-5.2): pancreatitis 0.9%, aseptic meningitis 0.9%, orchitis 0.6%, oophoritis 0.3%. Complication risk by age: 0% under five years, 1.9% at five to nine years, 19.2% at ten years and above (risk ratio 10.1, 95% CI 3.0-34.3; Fisher's p<0.001). All confirmed cases were unvaccinated for mumps. No retraction, expression of concern or erratum. Supports the statement that mumps vaccine is outside India's national schedule and that complication risk rises sharply with age. Cureus
- Quach HQ, Teodoro LI, Ratishvili T, Ovsyannikova IG, Jones SP, Joseph I, et al. Seroprevalence of mumps and rubella antibodies among Indian children: evidence of a mumps immunity gap. Vaccine. 2026;76:128291. PMID 41637894. Cross-sectional study of 508 children in Kerala. States: "India's National Immunization Program prioritizes rubella while excluding mumps." Mumps IgG seropositivity 78.5% (95% CI 74.8-81.9) against rubella 99.4% (95% CI 98.3-99.8). IgG titres for both declined with time since vaccination. No retraction, expression of concern or erratum. This is the second independent confirmation that mumps is not in India's national programme, and it supplies the seroprevalence figures. Vaccine
- Campbell KJ, Venkatesh A, Golan R, Tang Z, Shan G, Donelan W, et al. Impact of male genital tract infections on semen quality: a systematic review and meta-analysis. Fertility and Sterility. 2026;125(5):770-783. PMID 41825760. Control-comparator studies identified in PubMed, Web of Science and Embase; 51 studies in qualitative synthesis, 35 in quantitative meta-analysis, comparing men with documented genitourinary infection against non-infected controls. Mean differences: semen volume -0.37 mL (95% CI -0.64 to -0.09); sperm concentration -6.65 million/mL (-11.17 to -2.14, I2 90%); progressive motility -5.93 percentage points (-9.07 to -2.78); total sperm count -47.15 million (-91.42 to -2.88); morphology -0.76 percentage points (-1.19 to -0.33). RESULTS ALSO STATE: "Total motility, vitality, and deoxyribonucleic acid (DNA) fragmentation index were not significantly different between groups" and "most pregnancy and live birth outcomes did not significantly differ between infected and control groups". Human papillomavirus was associated with increased antisperm antibody prevalence (odds ratio 10.63, 95% CI 1.49-75.93); hepatitis B with increased miscarriage risk (odds ratio 1.43, 95% CI 1.05-1.93). Heterogeneity I2 66% to 95%; predominantly observational designs, warranting cautious interpretation. No retraction, expression of concern or erratum. Supports the effect-size correction and the antisperm-antibody correction. Fertility and Sterility
- Reich MC, Heide N, Humaidan PC, Esteves SC. Asymptomatic leukocytospermia and assisted reproductive technology outcomes: reason for concern? International Brazilian Journal of Urology. 2025;51(5). PMID 40209117. Narrative review. Leucocytospermia defined as at least one million white blood cells per millilitre of semen. Synthesis of meta-analyses and large retrospective studies indicates asymptomatic leucocytospermia does not negatively affect fertilisation, embryo development, clinical pregnancy or live birth, and standard sperm preparation with ICSI appears to neutralise any potential effect. "Given the absence of compelling evidence supporting its harmful impact on ART success, routine treatment of asymptomatic leukocytospermia — particularly with empiric antibiotics — is not recommended. Such interventions may disturb the natural immune balance, promote antibiotic resistance, and increase healthcare burdens without demonstrable benefit." The authors note selective treatment may be justified in recurrent implantation failure or early pregnancy loss. No retraction, expression of concern or erratum. Supports the recommendation against empiric antibiotics. International Brazilian Journal of Urology
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports. 2021;70(4):1-187. PMID 34292926. Epididymitis section retrieved from cdc.gov on 28 September 2026: "Acute epididymitis can be caused by STIs (e.g., C. trachomatis, N. gonorrhoeae, or M. genitalium)", and STI-related epididymitis is "usually accompanied by urethritis, which is frequently asymptomatic". Treatment objectives include "decreased potential for chlamydial or gonococcal epididymitis complications (e.g., infertility or chronic pain)". The document gives no incidence figure for infertility as a complication, and none is claimed on this page. No retraction, expression of concern or erratum. Supports the epididymitis organisms and the asymptomatic-urethritis point. Centers for Disease Control and Prevention (MMWR)
- Misell LM, Holochwost D, Boban D, Santi N, Shefi S, Hellerstein MK. A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo. Journal of Urology. 2006;175(1):242-6. PMID 16406920. Eleven men with normal sperm concentrations ingested deuterated water for three weeks, with semen collected every two weeks for up to 90 days. Labelled sperm were detected after a mean of 64 plus or minus 8 days, range 42 to 76. No retraction, expression of concern or erratum. Supports the three-month reassessment window. Journal of Urology
Frequently asked questions
Common questions on this topic.
I had mumps as a child. Should I be worried about my fertility?
Mumps before puberty is not the concern; the damage described in the literature follows mumps orchitis in post-pubertal males. If you had mumps as a small child with no testicular pain or swelling, there is no reason from that history alone to expect a problem. If you had mumps as a teenager or adult with a painful, swollen testicle, put it in your history when you see anyone about fertility, and ask for a semen analysis rather than waiting.
A semen culture grew bacteria but I have no symptoms. Does that need treating?
It needs interpreting before it needs treating. Significant bacteriospermia is defined as more than a thousand colony-forming units per millilitre of a urinary tract pathogen in the ejaculate, and a urinary tract infection has to be excluded first. Even where an organism is found and cleared, the EAU summary of evidence records that antibiotic treatment may improve sperm quality without improving the probability of conception. Ask what organism, at what count, and what the treatment is expected to change.
Can fertility come back after an infection is treated?
It depends entirely on whether scarring followed, which is why the examination matters more than the culture. Where the infection caused inflammation but no obstruction, semen parameters can recover, and about three months is the honest window to reassess because a cycle of sperm production was measured at a mean of 64 days. Where the epididymis or the vas has been blocked — which is characteristic of genital tuberculosis — curing the infection does not reopen it, and surgically retrieved sperm with ICSI is usually what is available.
Should I get a semen tuberculosis PCR done?
Not as a screening test. In 100 infertile men with unexplained obstructive azoospermia, semen tuberculosis PCR identified nobody who had not already been identified by history and examination, and of the four men treated on the strength of it, none had any improvement in semen parameters. The authors concluded it is not indicated in that situation. A scrotal examination and a tuberculosis history are the useful steps.
Does my partner need to be treated too?
If a sexually transmitted infection is known or suspected, yes — this is the one Strong recommendation the EAU guideline makes in this area: refer sexual partners for evaluation and treatment. The reason is practical rather than moral. Treating one partner and not the other produces reinfection, and repeated episodes of epididymitis are what cause the scarring that matters.
Can an infection be the reason a semen report is abnormal, with no symptoms at all?
It can, and the urethritis accompanying chlamydia or gonorrhoea is frequently asymptomatic, which is how these infections reach the epididymis unnoticed. But the effect size found in the pooled data is modest — sperm concentration about 6.65 million/mL lower and progressive motility about 5.93 percentage points lower than non-infected controls, with wide heterogeneity — so an infection is rarely the whole explanation for a markedly abnormal report. It is worth excluding, not worth assuming.


